GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sudarshan Pharma Industries Ltd (BOM:543828) » Definitions » ROC %

Sudarshan Pharma Industries (BOM:543828) ROC % : 9.56% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sudarshan Pharma Industries ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Sudarshan Pharma Industries's annualized return on capital (ROC %) for the quarter that ended in Sep. 2024 was 9.56%.

As of today (2025-04-10), Sudarshan Pharma Industries's WACC % is 12.33%. Sudarshan Pharma Industries's ROC % is 10.27% (calculated using TTM income statement data). Sudarshan Pharma Industries earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Sudarshan Pharma Industries ROC % Historical Data

The historical data trend for Sudarshan Pharma Industries's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sudarshan Pharma Industries ROC % Chart

Sudarshan Pharma Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROC %
Get a 7-Day Free Trial 10.68 10.50 13.26 11.43 9.45

Sudarshan Pharma Industries Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.20 10.79 7.88 10.94 9.56

Sudarshan Pharma Industries ROC % Calculation

Sudarshan Pharma Industries's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2024 is calculated as:

ROC % (A: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2023 ) + Invested Capital (A: Mar. 2024 ))/ count )
=218.524 * ( 1 - 24.78% )/( (1259.251 + 2218.319)/ 2 )
=164.3737528/1738.785
=9.45 %

where

Invested Capital(A: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2324.78 - 948.344 - ( 117.185 - max(0, 1184.768 - 1986.216+117.185))
=1259.251

Invested Capital(A: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2831.255 - 611.5 - ( 1.436 - max(0, 1608.241 - 2415.725+1.436))
=2218.319

Sudarshan Pharma Industries's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=309.136 * ( 1 - 26.2% )/( (2218.319 + 2553.538)/ 2 )
=228.142368/2385.9285
=9.56 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2831.255 - 611.5 - ( 1.436 - max(0, 1608.241 - 2415.725+1.436))
=2218.319

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3202.306 - 629.599 - ( 19.169 - max(0, 1930.115 - 2592.281+19.169))
=2553.538

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sudarshan Pharma Industries  (BOM:543828) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Sudarshan Pharma Industries's WACC % is 12.33%. Sudarshan Pharma Industries's ROC % is 10.27% (calculated using TTM income statement data). Sudarshan Pharma Industries earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Sudarshan Pharma Industries ROC % Related Terms

Thank you for viewing the detailed overview of Sudarshan Pharma Industries's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sudarshan Pharma Industries Business Description

Traded in Other Exchanges
N/A
Address
S V Road, 301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, Borivali (West), Mumbai, MH, IND, 400092
Sudarshan Pharma Industries Ltd is engaged in business in Pharmaceutical formulation & Chemical - Bulk drugs, API, Specialty chemicals, and Solvents in India and abroad.

Sudarshan Pharma Industries Headlines

No Headlines